{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:55:47Z","timestamp":1775195747763,"version":"3.50.1"},"reference-count":16,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2015,9,17]],"date-time":"2015-09-17T00:00:00Z","timestamp":1442448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0135309","type":"journal-article","created":{"date-parts":[[2015,9,17]],"date-time":"2015-09-17T18:28:17Z","timestamp":1442514497000},"page":"e0135309","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":57,"title":["The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial"],"prefix":"10.1371","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct00528112","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Kristina","family":"Gemzell-Danielsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Apter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Hauck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Schmelter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Rybowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,9,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.contraception.2010.01.010","article-title":"Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women","volume":"81","author":"R Lyus","year":"2010","journal-title":"Contraception"},{"key":"ref2","unstructured":"World Health Organization (2010) Medical eligibility criteria for contraceptive use: fourth edition. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241563888_eng.pdf\" xlink:type=\"simple\">http:\/\/whqlibdoc.who.int\/publications\/2010\/9789241563888_eng.pdf<\/ext-link>. Accessed 11 May 2015."},{"key":"ref3","unstructured":"Centers for Disease Control and Prevention (2010) MMWR: Sexually transmitted diseases treatment guidelines 2010. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cdc.gov\/std\/treatment\/2010\/pid.htm\" xlink:type=\"simple\">http:\/\/www.cdc.gov\/std\/treatment\/2010\/pid.htm<\/ext-link>. Accessed 21 October 2014."},{"key":"ref4","unstructured":"Faculty of the Royal College of Obstetricians and Gynaecologists (2009) UK medical eligibility for contraceptive use. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fsrh.org\/pdfs\/UKMEC2009.pdf\" xlink:type=\"simple\">http:\/\/www.fsrh.org\/pdfs\/UKMEC2009.pdf<\/ext-link>. Accessed 27 July 2015."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/AOG.0b013e31824aca39","article-title":"Health care provider attitudes and practices related to intrauterine devices for nulliparous women","volume":"119","author":"CP Tyler","year":"2012","journal-title":"Obstet Gynecol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.fertnstert.2011.12.003","article-title":"A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena","volume":"97","author":"K Gemzell-Danielsson","year":"2012","journal-title":"Fertil Steril"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0000000000000019","article-title":"Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial","volume":"122","author":"AL Nelson","year":"2013","journal-title":"Obstet Gynecol"},{"key":"ref8","unstructured":"Bayer HealthCare Pharmaceuticals Inc. (2012) Cost of unintended pregnancy: model technical report\u2014UK."},{"key":"ref9","unstructured":"Bayer HealthCare Pharmaceuticals Inc (2013) Skyla<sup>\u00ae<\/sup> Prescribing Information."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/13625187.2012.700744","article-title":"A review of barriers and myths preventing the more widespread use of intrauterine contraception in nulliparous women","volume":"17","author":"K Black","year":"2012","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/humupd\/dmt022","article-title":"Management of pain associated with the insertion of intrauterine contraceptives","volume":"19","author":"K Gemzell-Danielsson","year":"2013","journal-title":"Hum Reprod Update"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.contraception.2011.05.012","article-title":"Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas","volume":"84","author":"MV Bahamondes","year":"2011","journal-title":"Contraception"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.contraception.2007.01.018","article-title":"The levonorgestrel intrauterine system in nulliparous women","volume":"75","author":"S Prager","year":"2007","journal-title":"Contraception"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/13814780409044540","article-title":"Complications of the intrauterine device in nulliparous and parous women","volume":"10","author":"HM Veldhuis","year":"2004","journal-title":"Eur J Gen Pract"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.contraception.2010.04.041","article-title":"Rates of continuation and expulsion of intrauterine contraception at 12 months in nulliparous and adolescent women","volume":"82","author":"T Madden","year":"2010","journal-title":"Contraception"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/bmj.321.7258.450","article-title":"Ectopic pregnancy with oral contraceptive use has been overlooked","volume":"321","author":"WL Larimore","year":"2000","journal-title":"BMJ"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0135309","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T14:20:57Z","timestamp":1540218057000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0135309"}},"subtitle":[],"editor":[{"given":"Sharon","family":"Cameron","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,17]]},"references-count":16,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2015,9,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0135309","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,17]]}}}